Search results

1 – 3 of 3
Per page
102050
Citations:
Loading...
Available. Open Access. Open Access
Article
Publication date: 23 October 2019

Sharon R. Sznitman, Monica J. Barratt, Tom Decorte, Pekka Hakkarainen, Simon Lenton, Gary Potter, Bernd Werse and Chris Wilkins

It is conceivable that cannabis cultivators who grow for medical purposes aim to improve the therapeutic index of their cannabis by attempting to produce particular concentrations…

1146

Abstract

Purpose

It is conceivable that cannabis cultivators who grow for medical purposes aim to improve the therapeutic index of their cannabis by attempting to produce particular concentrations of CBD and/or THC. The purpose of this paper is to examine whether small-scale medical cannabis growers differ from those growing for recreational reasons in terms of self-assessed concentrations of THC and CBD in the cannabis they grow.

Design/methodology/approach

Data collection was conducted online from a convenience sample of 268 cannabis growers visiting a popular Israeli cannabis internet forum. χ2 and Kruskal–Wallis H were used to test bivariate associations between medical and recreational cannabis cultivators in terms of self-assessed cannabinoid concentrations.

Findings

In total, 40 percent of cannabis growers reported that they grow for medical purposes. Medical cannabis growers were more likely to report that they thought they knew the cannabinoid concentrations of the cannabis they grew and they reported higher self-assessed concentrations of THC, but not CBD.

Originality/value

Compared to recreational growers, medical cannabis growers are more likely to strive to be informed in terms of the content of their cannabis. Medical growers may also be attempting to grow more potent THC but not CBD cannabis.

Details

Drugs and Alcohol Today, vol. 19 no. 4
Type: Research Article
ISSN: 1745-9265

Keywords

Access Restricted. View access options
Article
Publication date: 22 October 2021

Dennis Rosenberg and Sharon Sznitman

This study aimed to understand the extent to which cannabis-related risk perception and COVID-19-related health worries were associated with the reported reduction in sharing…

132

Abstract

Purpose

This study aimed to understand the extent to which cannabis-related risk perception and COVID-19-related health worries were associated with the reported reduction in sharing cannabis smoking products to mitigate the risk of the coronavirus transmission or infection. This association was tested in two different periods in terms of toughness of national lockdown policy imposed in the first months of the pandemic in Israel.

Design/methodology/approach

The study population included adult recreational cannabis users who completed one of the two online cross-sectional surveys dedicated to COVID-19 and the cannabis use situation in Israel in the first half of the 2020. The two surveys were conducted six weeks apart. One survey was conducted in the period when strict lockdown measures were in place (N1 = 376). The other survey was conducted in the period when many lockdown measures were lifted (N2 = 284). Differences between the samples regarding risk perception, health stressors and reduction in sharing cannabis products were assessed using t-test. Regression analysis was used to test the independent correlates of reported reduction in sharing cannabis products.

Findings

Means of risk perception, health stressors and reported reduction in sharing cannabis products were higher in the sample surveyed in the period of the strict lockdown measures than in the sample surveyed in the period of eased lockdown measures. Risk perception was associated with reported reduction in sharing cannabis products only in the sample surveyed in the period of strict lockdown measures. In contrast, health stressors were related to reported reduction in sharing cannabis products in both samples.

Social implications

Health stressors may represent a more stable mechanism by which cannabis users engage in protective behavior during the pandemic than risk perceptions.

Originality/value

To the best of the authors’ knowledge, the current research is one of the first studies that examine the associations among risk perception, primary stressors and protective behavior in recreational cannabis users while referring to cannabis-related behavior other than use.

Details

Drugs and Alcohol Today, vol. 22 no. 1
Type: Research Article
ISSN: 1745-9265

Keywords

Access Restricted. View access options
Article
Publication date: 29 May 2018

Chris Wilkins, Sharon Sznitman, Tom Decorte, Pekka Hakkarainen and Simon Lenton

The purpose of this paper is to explore the characteristics of small-scale cannabis cultivation in New Zealand and Israel.

380

Abstract

Purpose

The purpose of this paper is to explore the characteristics of small-scale cannabis cultivation in New Zealand and Israel.

Design/methodology/approach

An online survey of predominantly small-scale cannabis cultivators had previously been conducted in 11 countries in 2012/2013. The same core online survey was subsequently conducted in New Zealand and Israel in 2016/2017, and comparisons made with the original 11 countries.

Findings

Only around one third of the New Zealand and Israeli cannabis growers had sold cannabis, and the majority of these did so only to cover the costs of cultivation. The median number of cannabis plants cultivated per crop by the New Zealand and Israeli growers was five and two, respectively. The leading reasons provided for growing cannabis by both the New Zealand and Israeli growers were to provide cannabis for personal use and to share with others. A higher proportion of New Zealand than Israeli growers reported growing cannabis for medicinal reasons. A total of 16 per cent of the New Zealand and 17 per cent of Israeli growers had come into contact with the police due to their cannabis cultivation. The findings suggest small-scale cannabis cultivation in New Zealand and Israel is largely a means of “social supply” of cannabis, and this is consistent with the findings from the original 11 countries. The higher incidence of growing cannabis for medicinal purposes in New Zealand may reflect the limited official access to medical cannabis. Significant minorities of small-scale cannabis growers in both countries had contact with police, putting them at risk of the negative consequences of a criminal conviction.

Originality/value

To date, the research into cannabis cultivation has largely consisted of studies of individual countries. However, given the global popularity of cannabis use, and the recent spread of cannabis cultivation to countries that traditionally have not produced cannabis, via utilisation of indoor growing techniques, there is now a strong case for international comparative research. Following the success of the surveys in the original 11 countries, New Zealand and Israeli members of the Global Cannabis Cultivation Research Consortium international collaboration chose to undertake surveys in their own countries in 2016/2017.

Details

Drugs and Alcohol Today, vol. 18 no. 2
Type: Research Article
ISSN: 1745-9265

Keywords

1 – 3 of 3
Per page
102050